X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3) 3
cardiovascular disease (2) 2
cardiovascular-disease (2) 2
clinical trials (2) 2
heart attacks (2) 2
index medicus (2) 2
myocardial-infarction (2) 2
risk (2) 2
abridged index medicus (1) 1
adrenergic beta-antagonists - administration & dosage (1) 1
adrenergic beta-antagonists - therapeutic use (1) 1
aged (1) 1
aged, anti-inflammatory agents, antibodies, monoclonal, atherosclerosis, c-reactive protein, cardiovascular diseases, dose-response relationship, drug, double-blind method, female, humans, incidence, infection, interleukin-1beta, lipids, male, middle aged, myocardial infarction, neutropenia, secondary prevention, stroke (1) 1
analysis (1) 1
angina (1) 1
angina pectoris (1) 1
anti-inflammatory agents - administration & dosage (1) 1
anti-inflammatory agents - adverse effects (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
anticoagulants (1) 1
arrhythmias, cardiac - etiology (1) 1
arteriosclerosis (1) 1
aspirin (1) 1
aspirin - adverse effects (1) 1
aspirin - therapeutic use (1) 1
atherosclerosis (1) 1
atherosclerosis - blood (1) 1
atherosclerosis - drug therapy (1) 1
atrial fibrillation - etiology (1) 1
atrial fibrillation - therapy (1) 1
blood circulation disorders (1) 1
c-reactive protein (1) 1
c-reactive protein - metabolism (1) 1
california (1) 1
canakinumab (1) 1
cardiac & cardiovascular systems (1) 1
cardiac arrhythmia (1) 1
cardiac pacing, artificial (1) 1
cardiac patients (1) 1
cardiology (1) 1
cardiomyopathy, hypertrophic (1) 1
cardiomyopathy, hypertrophic - diagnosis (1) 1
cardiomyopathy, hypertrophic - physiopathology (1) 1
cardiomyopathy, hypertrophic - therapy (1) 1
cardiovascular diseases (1) 1
cardiovascular diseases - epidemiology (1) 1
cardiovascular diseases - mortality (1) 1
care and treatment (1) 1
catheter ablation (1) 1
cerebral infarction (1) 1
cholesterol (1) 1
classification (1) 1
climate change (1) 1
clinical medicine (1) 1
clinical trial design (1) 1
clinical-trials (1) 1
clonal hematopoiesis (1) 1
clopidogrel (1) 1
convergence (1) 1
convergent evolution (1) 1
coronary heart disease (1) 1
coronary-artery-disease (1) 1
cytokines (1) 1
death, sudden, cardiac - epidemiology (1) 1
disease prevention (1) 1
disturbance history (1) 1
dose-response relationship, drug (1) 1
double-blind method (1) 1
drug dosages (1) 1
drug therapy (1) 1
drug therapy, combination (1) 1
ecology (1) 1
ecosystems (1) 1
ethanol - therapeutic use (1) 1
female (1) 1
fire (1) 1
forestry (1) 1
forestry management (1) 1
genetic therapy (1) 1
geography, physical (1) 1
geosciences, multidisciplinary (1) 1
grassland (1) 1
health aspects (1) 1
health risk assessment (1) 1
heart septum - surgery (1) 1
heart-disease (1) 1
hemorrhage - chemically induced (1) 1
incidence (1) 1
infection - etiology (1) 1
inflammation (1) 1
innate immunity (1) 1
interleukin-1-beta inhibition (1) 1
interleukin-1beta - antagonists & inhibitors (1) 1
interleukin-1beta - immunology (1) 1
israel (1) 1
klinisk medicin (1) 1
landscape dynamics (1) 1
landscape ecology (1) 1
life sciences (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 11/2003, Volume 42, Issue 9, pp. 1687 - 1713
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article
Journal Article